{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:00:17Z","timestamp":1767193217576,"version":"3.45.0"},"reference-count":42,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"abstract":"Abstract<\/jats:title>\n \n Context<\/jats:title>\n Growth hormone (GH) enhances muscle strength and aerobic capacity in adults with GH deficiency, but GH effects in skeletal muscle are less well characterized in youth.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the impact of GH on skeletal muscle in boys with significant short stature (SS) compared with age-matched, normally growing controls.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This was an open-label comparator at an outpatient endocrine clinic. Participants were 45 prepubertal boys, SS, n = 30 (isolated GH deficiency or idiopathic SS) (mean [SE] age: 8.9 \u00b1 0.3 years; height SDS: \u22122.3 \u00b1 0.1); controls, n = 15 (8.8 \u00b1 0.4 years; HT SDS: \u22120.3 \u00b1 0.2). Anthropometry, fat-free mass, resting energy expenditure (REE) and muscle testing was performed at baseline, and 6 and 12 months after daily GH (SS group) or observation (controls). The main outcome measures were skeletal muscle strength (isometric dynamometry (flexion\/extension) upper and lower extremities) (principal), power (vertical jump), endurance (modified pushups), and agility (timed shuttle-runs); fat-free mass accrual and REE (secondary).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n At baseline, the SS group had lower muscle strength in upper body (P \u2264 .027) and lower body (P \u2264 .007) vs controls, similar lower body muscle power and agility, but lower endurance (P = .048). Baseline differences were significantly less after GH treatment, with values in children approaching those of controls by 12 months. Adjusting for height SDS and fat-free mass between groups decreases detected differences in upper extremity muscle strength and endurance, but lower extremity muscle strength differences persist. No differences in REE were detected.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Boys with significant SS have quantifiable deficits in upper and lower body skeletal muscle strength, and lower physical endurance than normally statured controls. GH treatment for 12 months can improve these metrics in prepubertal boys with SS.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf203","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:52:04Z","timestamp":1743493924000},"page":"3517-3524","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Growth Hormone on Skeletal Muscle Strength, Power, Endurance, and Agility in Prepubertal Boys With Short Stature"],"prefix":"10.1210","volume":"110","author":[{"given":"Ashish","family":"Malpani","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurah","family":"Welch","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Plummer","sequence":"additional","affiliation":[{"name":"Physical Therapy and Rehabilitation Department, Wolfson Children's Hospital , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Churilla","sequence":"additional","affiliation":[{"name":"Department of Kinesiology, University of North Florida , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Benson","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jobayer","family":"Hossain","sequence":"additional","affiliation":[{"name":"Biostatistics Program, Nemours Children's Health , Wilmington, DE 19803 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Permuy","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauri","family":"Carakushansky","sequence":"additional","affiliation":[{"name":"Nemours Children's Health , Orlando, FL 32827 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-3852","authenticated-orcid":false,"given":"Nelly","family":"Mauras","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children's Health , Jacksonville, FL 32207 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"16","key":"2025111718530244500_dgaf203-B1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199910143411607","article-title":"Growth hormone therapy in adults and children","volume":"341","author":"Vance","year":"1999","journal-title":"N Engl Med"},{"issue":"5","key":"2025111718530244500_dgaf203-B2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/cen.12196","article-title":"Protein markers predict body composition during growth hormone treatment in short prepubertal children","volume":"79","author":"Decker","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2025111718530244500_dgaf203-B3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/meta.2001.22510","article-title":"Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy","volume":"50","author":"Roemmich","year":"2001","journal-title":"Metabolism"},{"issue":"5","key":"2025111718530244500_dgaf203-B4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bone.2005.06.012","article-title":"Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency","volume":"37","author":"H\u00f6gler","year":"2005","journal-title":"Bone"},{"issue":"6","key":"2025111718530244500_dgaf203-B5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ghir.2007.04.011","article-title":"Growth hormone action in puberty: effects by gender","volume":"17","author":"Mauras","year":"2007","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"2025111718530244500_dgaf203-B6","doi-asserted-by":"crossref","first-page":"e1522","DOI":"10.1210\/clinem\/dgae011","article-title":"Approach to the peripubertal patient with short stature","volume":"109","author":"Torres-Santiago","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025111718530244500_dgaf203-B7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tem.2011.02.005","article-title":"Growth hormone and physical performance","volume":"22","author":"Birzniece","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2025111718530244500_dgaf203-B8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025111718530244500_dgaf203-B9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr Pract"},{"issue":"6","key":"2025111718530244500_dgaf203-B10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.beem.2016.11.012","article-title":"Muscle and skeletal health in children and adolescents with GH deficiency","volume":"30","author":"Improda","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2025111718530244500_dgaf203-B11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2265.2009.03716.x","article-title":"The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis","volume":"72","author":"Widdowson","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2025111718530244500_dgaf203-B12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans","volume":"86","author":"Horber","year":"1990","journal-title":"J Clin Invest"},{"issue":"4","key":"2025111718530244500_dgaf203-B13","first-page":"1686","article-title":"Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025111718530244500_dgaf203-B14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/me.2014-1099","article-title":"Minireview: mechanisms of growth hormone-mediated gene regulation","volume":"28","author":"Chia","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2025111718530244500_dgaf203-B15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/er.2004-0022","article-title":"The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults","volume":"27","author":"Woodhouse","year":"2006","journal-title":"Endocr Rev"},{"issue":"5","key":"2025111718530244500_dgaf203-B16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1475-097X.1994.tb00411.x","article-title":"Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation","volume":"14","author":"Sartorio","year":"1994","journal-title":"Clin Physiol"},{"issue":"2","key":"2025111718530244500_dgaf203-B17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol (1985)"},{"issue":"2","key":"2025111718530244500_dgaf203-B18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"2025111718530244500_dgaf203-B19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2008-1538","article-title":"Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults","volume":"94","author":"G\u00f6therstr\u00f6m","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111718530244500_dgaf203-B20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025111718530244500_dgaf203-B21","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1210\/jc.2007-2600","article-title":"Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition","volume":"93","author":"Schweizer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025111718530244500_dgaf203-B22","first-page":"662","article-title":"Growth hormone therapy and children with idiopathic short stature: a viable option?","volume":"25","author":"Willhaus","year":"1999","journal-title":"Pediatr Nurs"},{"issue":"5","key":"2025111718530244500_dgaf203-B23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bone.2007.06.028","article-title":"Similar effects of long-term exogenous growth hormone (GH) on bone and muscle parameters: a pQCT study of GH-deficient and small-for-gestational-age (SGA) children","volume":"41","author":"Schweizer","year":"2007","journal-title":"Bone"},{"key":"2025111718530244500_dgaf203-B24","doi-asserted-by":"crossref","first-page":"101558","DOI":"10.1016\/j.ghir.2023.101558","article-title":"Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature","volume":"72\u201373","author":"Lavi","year":"2023","journal-title":"Growth Horm IGF Res"},{"key":"2025111718530244500_dgaf203-B25","doi-asserted-by":"crossref","first-page":"1122287","DOI":"10.3389\/fendo.2023.1122287","article-title":"Increase of jump performance during GH treatment in short children born SGA","volume":"14","author":"Schweizer","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2025111718530244500_dgaf203-B26","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1210\/jcem.86.10.7897","article-title":"GH is needed for the maturation of muscle mass and strength in adolescents","volume":"86","author":"Hulth\u00e9n","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025111718530244500_dgaf203-B27","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1210\/jc.2013-2236","article-title":"Growth hormone and muscle strength in children","volume":"98","author":"Polak","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025111718530244500_dgaf203-B28","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1177\/0363546520920591","article-title":"The use of recombinant human growth hormone to protect against muscle weakness in patients undergoing anterior cruciate ligament reconstruction: a pilot, randomized placebo-controlled trial","volume":"48","author":"Mendias","year":"2020","journal-title":"Am J Sports Med"},{"issue":"7","key":"2025111718530244500_dgaf203-B29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2522\/ptj.20090350","article-title":"Measuring physical fitness in children who are 5 to 12 years old with a test battery that is functional and easy to administer","volume":"91","author":"Fj\u00f8rtoft","year":"2011","journal-title":"Phys Ther"},{"issue":"1","key":"2025111718530244500_dgaf203-B30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-2474-13-176","article-title":"Stature is an essential predictor of muscle strength in children","volume":"13","author":"Hogrel","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"2025111718530244500_dgaf203-B31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1203\/00006450-200204000-00017","article-title":"Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics","volume":"51","author":"Rauch","year":"2002","journal-title":"Pediatr Res"},{"issue":"6","key":"2025111718530244500_dgaf203-B32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/mus.1070","article-title":"Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children","volume":"24","author":"Escolar","year":"2001","journal-title":"Muscle Nerve"},{"issue":"7","key":"2025111718530244500_dgaf203-B33","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1210\/jc.2012-4201","article-title":"Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study","volume":"98","author":"Simon","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025111718530244500_dgaf203-B34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.2002.17.6.1095","article-title":"Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit","volume":"17","author":"Schoenau","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025111718530244500_dgaf203-B35","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/jc.2005-2762","article-title":"Evidence for hypermetabolism in boys with constitutional delay of growth and maturation","volume":"91","author":"Han","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025111718530244500_dgaf203-B36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jpeds.2010.09.006","article-title":"Effects of growth hormone and nutritional therapy in boys with constitutional growth delay: a randomized controlled trial","volume":"158","author":"Han","year":"2011","journal-title":"J Pediatr"},{"issue":"8","key":"2025111718530244500_dgaf203-B37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/cells9081773","article-title":"Implications of insulin-like growth factor-1 in skeletal muscle and Various diseases","volume":"9","author":"Ahmad","year":"2020","journal-title":"Cells"},{"issue":"6","key":"2025111718530244500_dgaf203-B38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tem.2013.03.004","article-title":"The therapeutic potential of IGF-I in skeletal muscle repair","volume":"24","author":"Song","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2025111718530244500_dgaf203-B39","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/acel.12954","article-title":"Effects of IGF-1 isoforms on muscle growth and sarcopenia","volume":"18","author":"Ascenzi","year":"2019","journal-title":"Aging Cell"},{"key":"2025111718530244500_dgaf203-B40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bone.2015.04.036","article-title":"Role of IGF-I signaling in muscle bone interactions","volume":"80","author":"Bikle","year":"2015","journal-title":"Bone"},{"issue":"5","key":"2025111718530244500_dgaf203-B41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1203\/00006450-200011000-00010","article-title":"Growth hormone stimulation testing in both short and normal statured children: use of an immunofunctional assay","volume":"48","author":"Mauras","year":"2000","journal-title":"Pediatr Res"},{"issue":"5","key":"2025111718530244500_dgaf203-B42","first-page":"2211","article-title":"Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects","volume":"86","author":"Hayes","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf203\/62838947\/dgaf203.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3517\/62838947\/dgaf203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/12\/3517\/62838947\/dgaf203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:53:17Z","timestamp":1763423597000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/12\/3517\/8103704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,4,2]]},"published-print":{"date-parts":[[2025,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf203","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,4,2]]}}}